Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1520433
PUBLISHER: IMARC | PRODUCT CODE: 1520433
In-vitro Colorectal Cancer Screening Tests Market Report by Product, Imaging Type, End User, and Region 2024-2032
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global in-vitro colorectal cancer screening tests market size reached US$ 997.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,590.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.
In-Vitro Colorectal Cancer Screening Tests Market Trends:
The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global In-vitro colorectal cancer screening tests market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, imaging type and end user.
Breakup by Product:
Fecal Occult Blood Tests
Guaiac FOB Stool Test
Immuno-FOB Agglutination Test
Lateral Flow Immuno-FOB Test
Immuno-FOB ELISA Test
Biomarker Tests
Tumor M2-PK Stool Test
Transferrin Assays
CRC DNA Screening Tests
Methylated Gene Testing
Panel DNA Tests
Breakup by Imaging Type:
Colonoscopy
Proctoscopy
CT Scan
Ultrasound
MRI
PET Scan
Breakup by End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.
Key Questions Answered in This Report
- 1. What was the size of the global in-vitro colorectal cancer screening tests market in 2023?
- 2. What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?
- 4. What are the key factors driving the global in-vitro colorectal cancer screening tests market?
- 5. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?
- 6. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?
- 7. What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?
- 8. What are the key regions in the global in-vitro colorectal cancer screening tests market?
- 9. Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?
Product Code: SR112024A5383
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global In-vitro Colorectal Cancer Screening Tests Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Fecal Occult Blood Tests
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Guaiac FOB Stool Test
- 6.1.2.2 Immuno-FOB Agglutination Test
- 6.1.2.3 Lateral Flow Immuno-FOB Test
- 6.1.2.4 Immuno-FOB ELISA Test
- 6.1.3 Market Forecast
- 6.2 Biomarker Tests
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Tumor M2-PK Stool Test
- 6.2.2.2 Transferrin Assays
- 6.2.3 Market Forecast
- 6.3 CRC DNA Screening Tests
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Methylated Gene Testing
- 6.3.2.2 Panel DNA Tests
- 6.3.3 Market Forecast
7 Market Breakup by Imaging Type
- 7.1 Colonoscopy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Proctoscopy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 CT Scan
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Ultrasound
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 MRI
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 PET Scan
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Diagnostic Laboratories
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Beckman Coulter Inc. (Danaher Corporation)
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Eiken Chemical Co. Ltd.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Epigenomics AG
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Exact Sciences Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Hemosure Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Immunostics Inc. (Boditech Med Inc.)
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Medline Industries LP
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 Merck KGaA
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Qiagen N.V.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Quest Diagnostics Incorporated
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 R-Biopharm AG
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Siemens AG
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Sysmex Corporation
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
- 14.3.1 Beckman Coulter Inc. (Danaher Corporation)
Product Code: SR112024A5383
List of Figures
- Figure 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Major Drivers and Challenges
- Figure 2: Global: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Product (in %), 2023
- Figure 5: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Imaging Type (in %), 2023
- Figure 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by End User (in %), 2023
- Figure 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Region (in %), 2023
- Figure 8: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: North America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: North America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: United States: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: United States: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Canada: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Canada: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: China: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: China: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Japan: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Japan: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: India: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: India: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: South Korea: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: South Korea: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Australia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Australia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Indonesia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Indonesia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Europe: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Europe: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Germany: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Germany: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: France: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: France: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Italy: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Italy: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Spain: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Spain: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Russia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Russia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Latin America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Latin America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Brazil: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Brazil: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Mexico: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Mexico: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Country (in %), 2023
- Figure 82: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Global: In-vitro Colorectal Cancer Screening Tests Industry: SWOT Analysis
- Figure 84: Global: In-vitro Colorectal Cancer Screening Tests Industry: Value Chain Analysis
- Figure 85: Global: In-vitro Colorectal Cancer Screening Tests Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Imaging Type (in Million US$), 2024-2032
- Table 4: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 5: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Competitive Structure
- Table 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.